Sort
53,477 grants matching “addiction”
Characterization of Sexual Dimorphism in the Brain
$520,159Nirao Mahesh Shah · Stanford University · R01 · FY2017 · NS
Navigator Enhanced Case Management for Jail Inmates
$520,117Janet Myers · University Of California, San Francisco · R01 · FY2009 · DA
Neurocognitive Effects of Opiate Agonist Treatment in HIV Infected Drug Users
$520,108Julia H. Arnsten · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · DA
Bath Salts & the Illicit Drug Market: Use, Violence & Health Consequences
$520,006Eloise Emma Dunlap · National Development And Research Institutes, Inc. · R01 · FY2014 · DA
Bioengineering of Channelrhodopsins for Neurophotonic and Nanophotonic Applications
$520,000Kenneth J Rothschild · Trustees Of Boston University · · FY2017 · ENG
Studies with Nicotinic Null Mutant Mice
$519,960Michael J Marks · University Of Colorado · P30 · FY2012 · DA
Postdoctoral training in tobacco control
$519,914Pamela May Ling · University Of California, San Francisco · T32 · FY2017 · CA
Vital Signs In Opioid-Exposed Neonates
$519,859Namasivayam Ambalavanan · University Of Alabama At Birmingham · R01 · FY2021 · HD
Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer Agent
$519,807Seth J Field · Case Western Reserve University · R01 · FY2024 · CA
Evaluation of the efficacy and mechanisms of a novel intervention for chronic pain tailored to people living with HIV
$519,796Jessica S Merlin · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · MH
Modeling Initial Smoking Abstinence and Relapse Risk
$519,749Stephen T Higgins · University Of Vermont & St Agric College · R01 · FY2009 · DA
A Trial to Prevent Opioid Overdose: E.D. Based Intervention & Take-home Naloxone
$519,746Caleb Banta-Green · University Of Washington · R01 · FY2014 · DA
Nicotine Reinforcement and Aversion in Young Adult Light Smokers
$519,699Mehmet Sofuoglu · Yale University · R01 · FY2016 · DA
Informed Data-Driven Fusion of Behavior, Brain Function, and Genes
$519,652Vince D Calhoun · The Mind Research Network · R01 · FY2009 · EB
Reduction of opioid requirement associated with Auriculo-nerve stimulation following open surgery
$519,625Jacques E. Chelly · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DA
Intervention to Reduce Injection Drug Use
$519,610Robert E Booth · University Of Colorado Denver · R01 · FY2007 · DA
Early Exposure to Stimulants as a Risk Factor for Substance Abuse
$519,609Linda J. Porrino · Wake Forest University Health Sciences · R01 · FY2006 · DA
Imaging Core
$519,609Richard E Carson · University Of Pennsylvania · P30 · FY2023 · DA
Novel nAChR-Targeted Peptides
$519,551J Michael McIntosh · University Of Utah · R01 · FY2011 · MH
Is mental disorder a preventable cause of age-related disease? The Dunedin Study.
$519,551Terrie Edith Moffitt · Duke University · R01 · FY2009 · AG
Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment
$519,501Michael Scott Gordon · Friends Research Institute, Inc. · R01 · FY2021 · DA
Implementing Opioid Risk Reduction Strategies into Primary Care Practice
$519,474Karen Elizabeth Lasser · Boston Medical Center · R01 · FY2015 · DA
Investigating the mechanistic contribution of Cav1.2 channels in extinction of cocaine-associated memories
$519,447Anjali M Rajadhyaksha · Temple Univ Of The Commonwealth · R01 · FY2024 · DA
Topiramate for alcohol and cocaine dependence
$519,405Kyle Matthew Kampman · University Of Pennsylvania · R01 · FY2007 · AA
Individual Differences & Cocaine Effects on Impulsive Choice in Rat
$519,390Jane R. Taylor · Yale University · R01 · FY2022 · DA